Moshyk, Andriy
Royal Marsden NHS Foundation Trust · Swansea University · Bristol-Myers Squibb (United States) · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori · Istituto Oncologico Veneto · Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · European Institute of Oncology
2 papers on CoChatORCID 0000-0003-4895-7103
Most cited papers
- Verified
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J.-J., Rutkowski, P., Lao, C. D., Cowey, C. L., Schadendorf, D., Wagstaff, J., Dummer, R., et al. (2019) · New England Journal of Medicine
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 3,723
- Verified
Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada
Quon, P., Le, H. H., Raymond, V., Mtibaa, M., & Moshyk, A. (2016) · Journal of Medical Economics
Venous Thromboembolism Diagnosis and ManagementHealth Systems, Economic Evaluations, Quality of Life
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free